Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.3600
-0.04-8.95%
At close: -
$0.3888
0.038.00%
After Hours: Apr 4, 7:03 PM EDT
Comments
Loading...
Bolt Biotherapeutics Analyst Ratings and Price Targets | NASDAQ:BOLT | Benzinga
Bolt Biotherapeutics Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Bolt Biotherapeutics Corp from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stifel
Leerink Partners
SVB Leerink
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Bolt Biotherapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/25/2025 | Buy Now | — | HC Wainwright & Co. | Edward White49% | — | Reiterates | Neutral → Neutral | Get Alert |
| 03/25/2025 | Buy Now | — | Stifel | Stephen Willey50% | $1.5 → $1.25 | Maintains | Hold | Get Alert |
| 11/13/2024 | Buy Now | — | HC Wainwright & Co. | Edward White49% | — | Reiterates | → Neutral | Get Alert |
| 08/15/2024 | Buy Now | — | HC Wainwright & Co. | Edward White49% | — | Reiterates | → Neutral | Get Alert |
| 05/15/2024 | Buy Now | — | Leerink Partners | Daina Graybosch43% | $3 → $1 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/15/2024 | Buy Now | — | Jones Trading | Soumit Roy33% | — | Downgrade | Buy → Hold | Get Alert |
| 05/15/2024 | Buy Now | — | HC Wainwright & Co. | Edward White49% | — | Downgrade | Buy → Neutral | Get Alert |
| 05/15/2024 | Buy Now | — | Stifel | Stephen Willey50% | $6 → $1.5 | Downgrade | Buy → Hold | Get Alert |
| 05/15/2024 | Buy Now | — | Guggenheim | Michael Schmidt53% | — | Downgrade | Buy → Neutral | Get Alert |
| 03/22/2024 | Buy Now | — | HC Wainwright & Co. | Edward White49% | $8 → $8 | Maintains | Buy | Get Alert |
| 08/08/2023 | Buy Now | — | HC Wainwright & Co. | Edward White49% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | Buy Now | — | HC Wainwright & Co. | Edward White49% | → $8 | Reiterates | → Buy | Get Alert |
| 06/05/2023 | Buy Now | — | HC Wainwright & Co. | Edward White49% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 05/26/2023 | Buy Now | — | HC Wainwright & Co. | Edward White49% | → $8 | Reiterates | → Buy | Get Alert |
| 05/12/2023 | Buy Now | — | SVB Leerink | Daina Graybosch43% | → $4 | Upgrade | Market Perform → Outperform | Get Alert |
| 05/12/2023 | Buy Now | — | HC Wainwright & Co. | Edward White49% | → $8 | Reiterates | Buy → Buy | Get Alert |
| 03/30/2023 | Buy Now | — | HC Wainwright & Co. | Edward White49% | → $8 | Reiterates | → Buy | Get Alert |
| 01/24/2023 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $5 → $3 | Maintains | Equal-Weight | Get Alert |
| 10/04/2022 | Buy Now | — | HC Wainwright & Co. | Edward White49% | → $8 | Initiates | → Buy | Get Alert |
| 08/11/2022 | Buy Now | — | SVB Leerink | Daina Graybosch43% | $8 → $4 | Downgrade | Outperform → Market Perform | Get Alert |
| 05/17/2022 | Buy Now | — | Morgan Stanley | Matthew Harrison61% | $7 → $5 | Maintains | Equal-Weight | Get Alert |
FAQ
What is the target price for Bolt Biotherapeutics (BOLT) stock?
The latest price target for Bolt Biotherapeutics (NASDAQ:BOLT) was reported by HC Wainwright & Co. on March 25, 2025. The analyst firm set a price target for $0.00 expecting BOLT to fall to within 12 months (a possible -100.00% downside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bolt Biotherapeutics (BOLT)?
The latest analyst rating for Bolt Biotherapeutics (NASDAQ:BOLT) was provided by HC Wainwright & Co., and Bolt Biotherapeutics reiterated their neutral rating.
When was the last upgrade for Bolt Biotherapeutics (BOLT)?
The last upgrade for Bolt Biotherapeutics Inc happened on May 12, 2023 when SVB Leerink raised their price target to $4. SVB Leerink previously had a market perform for Bolt Biotherapeutics Inc.
When was the last downgrade for Bolt Biotherapeutics (BOLT)?
The last downgrade for Bolt Biotherapeutics Inc happened on May 15, 2024 when Leerink Partners changed their price target from $3 to $1 for Bolt Biotherapeutics Inc.
When is the next analyst rating going to be posted or updated for Bolt Biotherapeutics (BOLT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bolt Biotherapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bolt Biotherapeutics was filed on March 25, 2025 so you should expect the next rating to be made available sometime around March 25, 2026.
Is the Analyst Rating Bolt Biotherapeutics (BOLT) correct?
While ratings are subjective and will change, the latest Bolt Biotherapeutics (BOLT) rating was a reiterated with a price target of $0.00 to $0.00. The current price Bolt Biotherapeutics (BOLT) is trading at is $0.39, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.